2026 Global: Nasal Cannula Market-Competitive Review (2032) report
Description
The 2026 Global: Nasal Cannula Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Philips Respironics, headquartered in Amsterdam, Netherlands, is a leader in oxygen delivery and patient monitoring, offering nasal cannulas designed for home care, acute care, and neonatal settings. The company leverages Philips' medical devices platform to deliver reliable low-flow and humidified solutions with emphasis on safety, ease of use, and supply chain resilience. Fisher & Paykel Healthcare, based in Auckland, New Zealand, complements Philips with specialty respiratory therapies and disposables that include pediatric and adult nasal cannulas compatible with humidification systems. Teleflex Incorporated, headquartered in Wayne, United States, operates a diversified devices portfolio and markets nasal cannula products under its Hudson RCI line, used across hospital departments. Drägerwerk AG & Co. KGaA, based in Lübeck, Germany, contributes to critical care with airway devices and oxygen delivery accessories, including cannulas that support anesthesia. Intersurgical, headquartered in Woking, United Kingdom, supplies respiratory products such as nasal cannulas, connectors, and circuits for hospital settings.
Vapotherm, headquartered in Exeter, New Hampshire, United States, specializes in high-flow nasal cannula therapy, delivering heated humidified oxygen through patient-specific cannula systems that improve tolerance and outcomes in neonatal and adult populations. The company emphasizes scalable solutions for emergency departments, neonatal intensive care units, and home care, supported by a modular delivery platform and remote monitoring capabilities. ResMed, headquartered in San Diego, United States, dominates the CPAP and home oxygen landscape with extensive nasal cannula lines integrated into broader sleep and respiratory therapy ecosystems, including connected services and telemedicine-enabled care. Getinge AB, based in Gothenburg, Sweden, provides hospital equipment and disposables that include nasal cannulas, anti-kink connectors, and humidification accessories as part of comprehensive patient care workflows, particularly in sterilization-conscious environments. Together these players illustrate the market's breadth, spanning low-flow to high-flow therapy, inpatient and outpatient settings, and a shift toward integrated, digitally connected oxygen delivery. Industry consolidation reshapes access.
Smiths Medical, headquartered in London, United Kingdom, is a prominent supplier of respiratory care disposables, including nasal cannulas, connectors, and related accessories used across hospital and home settings. The company benefits from integration with the broader Smiths Group R&D network, enabling rapid product development, sterilization, and regulatory support in diverse markets. B. Braun Melsungen AG, headquartered in Melsungen, Germany, complements the nasal cannula market with a broad portfolio of single-use devices, infusion products, and patient-care solutions that address delivery efficiency, infection control, and supply chain resilience. Both firms actively pursue partnerships with hospitals, homecare providers, and distributors to expand access to oxygen therapy, particularly in emerging markets where outpatient oxygen support is increasingly emphasized. The competitive landscape thus reflects a mix of legacy medical groups, specialized respiratory suppliers, and vertically integrated manufacturers that leverage global manufacturing footprints, standardized interfaces, and cross-functional R&D to advance patient-centric oxygen therapy across settings worldwide.
Philips Respironics, headquartered in Amsterdam, Netherlands, is a leader in oxygen delivery and patient monitoring, offering nasal cannulas designed for home care, acute care, and neonatal settings. The company leverages Philips' medical devices platform to deliver reliable low-flow and humidified solutions with emphasis on safety, ease of use, and supply chain resilience. Fisher & Paykel Healthcare, based in Auckland, New Zealand, complements Philips with specialty respiratory therapies and disposables that include pediatric and adult nasal cannulas compatible with humidification systems. Teleflex Incorporated, headquartered in Wayne, United States, operates a diversified devices portfolio and markets nasal cannula products under its Hudson RCI line, used across hospital departments. Drägerwerk AG & Co. KGaA, based in Lübeck, Germany, contributes to critical care with airway devices and oxygen delivery accessories, including cannulas that support anesthesia. Intersurgical, headquartered in Woking, United Kingdom, supplies respiratory products such as nasal cannulas, connectors, and circuits for hospital settings.
Vapotherm, headquartered in Exeter, New Hampshire, United States, specializes in high-flow nasal cannula therapy, delivering heated humidified oxygen through patient-specific cannula systems that improve tolerance and outcomes in neonatal and adult populations. The company emphasizes scalable solutions for emergency departments, neonatal intensive care units, and home care, supported by a modular delivery platform and remote monitoring capabilities. ResMed, headquartered in San Diego, United States, dominates the CPAP and home oxygen landscape with extensive nasal cannula lines integrated into broader sleep and respiratory therapy ecosystems, including connected services and telemedicine-enabled care. Getinge AB, based in Gothenburg, Sweden, provides hospital equipment and disposables that include nasal cannulas, anti-kink connectors, and humidification accessories as part of comprehensive patient care workflows, particularly in sterilization-conscious environments. Together these players illustrate the market's breadth, spanning low-flow to high-flow therapy, inpatient and outpatient settings, and a shift toward integrated, digitally connected oxygen delivery. Industry consolidation reshapes access.
Smiths Medical, headquartered in London, United Kingdom, is a prominent supplier of respiratory care disposables, including nasal cannulas, connectors, and related accessories used across hospital and home settings. The company benefits from integration with the broader Smiths Group R&D network, enabling rapid product development, sterilization, and regulatory support in diverse markets. B. Braun Melsungen AG, headquartered in Melsungen, Germany, complements the nasal cannula market with a broad portfolio of single-use devices, infusion products, and patient-care solutions that address delivery efficiency, infection control, and supply chain resilience. Both firms actively pursue partnerships with hospitals, homecare providers, and distributors to expand access to oxygen therapy, particularly in emerging markets where outpatient oxygen support is increasingly emphasized. The competitive landscape thus reflects a mix of legacy medical groups, specialized respiratory suppliers, and vertically integrated manufacturers that leverage global manufacturing footprints, standardized interfaces, and cross-functional R&D to advance patient-centric oxygen therapy across settings worldwide.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
